These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 17074932

  • 1. Important steps in the development of cognitive-enhancing drugs in schizophrenia.
    Buchanan RW.
    Am J Psychiatry; 2006 Nov; 163(11):1867-9. PubMed ID: 17074932
    [No Abstract] [Full Text] [Related]

  • 2. Cognitive improvement in response to antipsychotic drugs: neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.
    Heinrichs RW.
    Arch Gen Psychiatry; 2007 Jun; 64(6):631-2. PubMed ID: 17548745
    [No Abstract] [Full Text] [Related]

  • 3. The effects of clozapine on cognitive functioning in schizophrenia.
    McGurk SR.
    J Clin Psychiatry; 1999 Jun; 60 Suppl 12():24-9. PubMed ID: 10372607
    [Abstract] [Full Text] [Related]

  • 4. Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment.
    Harvey PD, Keefe RS.
    Am J Psychiatry; 2001 Feb; 158(2):176-84. PubMed ID: 11156796
    [Abstract] [Full Text] [Related]

  • 5. The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity.
    Nuechterlein KH, Green MF, Kern RS, Baade LE, Barch DM, Cohen JD, Essock S, Fenton WS, Frese FJ, Gold JM, Goldberg T, Heaton RK, Keefe RS, Kraemer H, Mesholam-Gately R, Seidman LJ, Stover E, Weinberger DR, Young AS, Zalcman S, Marder SR.
    Am J Psychiatry; 2008 Feb; 165(2):203-13. PubMed ID: 18172019
    [Abstract] [Full Text] [Related]

  • 6. Improvement of cognitive dysfunction after treatment with second-generation antipsychotics.
    Weiss E, Kemmler G, Fleischhacker WW.
    Arch Gen Psychiatry; 2002 Jun; 59(6):572-3; author reply 573-5. PubMed ID: 12044210
    [No Abstract] [Full Text] [Related]

  • 7. Cognition, drug treatment, and functional outcome in schizophrenia: a tale of two transitions.
    Green MF.
    Am J Psychiatry; 2007 Jul; 164(7):992-4. PubMed ID: 17606645
    [No Abstract] [Full Text] [Related]

  • 8. Evaluating the effects of antipsychotics on cognition in schizophrenia. Collaborative Working Group on Clinical Trial Evaluations.
    J Clin Psychiatry; 1998 Jul; 59 Suppl 12():35-40. PubMed ID: 9766618
    [Abstract] [Full Text] [Related]

  • 9. The effects of second-generation antipsychotics on cognitive functioning and psychosocial outcome in schizophrenia.
    Weiss EM, Bilder RM, Fleischhacker WW.
    Psychopharmacology (Berl); 2002 Jun; 162(1):11-7. PubMed ID: 12107611
    [Abstract] [Full Text] [Related]

  • 10. Cognitive effects of conventional and atypical antipsychotics in schizophrenia.
    Sharma T.
    Br J Psychiatry Suppl; 1999 Jun; (38):44-51. PubMed ID: 10884899
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cognitive impairment as a target for pharmacological treatment in schizophrenia.
    Davidson M, Keefe RS.
    Schizophr Res; 1995 Sep; 17(1):123-9. PubMed ID: 8541245
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cognitive and functional effects of atypical antipsychotic medications.
    Harvey PD.
    J Clin Psychiatry; 2006 Oct; 67(10):e13. PubMed ID: 17107236
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.